Streetbeat News

Analyst Ratings

CC

RBC Capital analyst Arun Viswanathan maintains an Outperform rating on Chemours (NYSE:CC) but lowers the price target from $35 to $28.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:48 pm

WLK

RBC Capital analyst Arun Viswanathan maintains an Outperform rating on Westlake (NYSE:WLK) but lowers the price target from $174 to $170.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:46 pm

RCL

Stifel analyst Steven Wieczynski maintains a Buy rating on Royal Caribbean Group (NYSE:RCL) and raises the price target from $200 to $230.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:45 pm

ANIP

MNKTQ

ANI Pharmaceuticals is shifting its focus from generics to high-margin brand assets, particularly in rare diseases, with Cortrophin Gel as a key product. Piper Sandler initiated coverage with an Overweight rating and a $68 price target. ANI's acquisition of Alimera Sciences enhances its market reach.

Portfolio Pulse from Vandana Singh

October 11, 2024 | 5:40 pm

DPZ

Deutsche Bank analyst Lauren Silberman maintains a Buy rating on Domino's Pizza (NYSE:DPZ) but lowers the price target from $500 to $480.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:40 pm

SKT

B of A Securities has maintained a Neutral rating on Tanger (NYSE:SKT) while raising the price target from $31 to $35.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:38 pm

MAC

B of A Securities has maintained a Neutral rating on Macerich (NYSE:MAC) while raising the price target from $17 to $19.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:36 pm

ABNB

B of A Securities has maintained a Neutral rating on Airbnb (NASDAQ:ABNB) while raising its price target from $132 to $142.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:34 pm

NU

Nu Holdings (NYSE:NU) has seen unusual options activity with over 11 transactions totaling $1,152,917, including 9 puts worth $1,171,442. The options activity suggests a price range of $12.0 to $14.0. The stock is currently trading at $13.6, up 1.23%, with a consensus target price of $15.0. Analysts maintain a neutral rating.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 5:34 pm

ARHS

B of A Securities has maintained a Buy rating on Arhaus (NASDAQ:ARHS) but has lowered the price target from $18 to $15.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:33 pm